Twice-daily budesonide inhalation suspension in infants and children <4 and ≥4 years of age with persistent asthma

Journal of Asthma

Volumn 39, Issue 3, 2002, Pages 227-237

  Mendelson, Louis ^a   Cook, David ^a   Cruz Rivera, Mario ^a   Fitzpatrick, Sherahe ^a   Smith, Joseph A ^a  

^a Connecticut Allergy/Asthma Center ^*  (United States)

Author keywords

Asthma; Budesonide inhalation suspension; Corticosteroids; Inhaled; Nebulization; Pediatric

Indexed keywords

BUDESONIDE; CORTICOTROPIN; HYDROCORTISONE; TETRACOSACTIDE;

ARTICLE; ASTHMA; BRONCHOSPASM; CANDIDIASIS; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; CONJUNCTIVITIS; COUGHING; DRUG EFFICACY; DRUG SAFETY; DRUG USE; EAR INFECTION; EPISTAXIS; FEMALE; FEVER; GASTROENTERITIS; HEADACHE; HUMAN; HYDROCORTISONE BLOOD LEVEL; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL NEBULIZER; NEBULIZATION; OTITIS MEDIA; PHARYNGITIS; PURPURA; RASH; RESPIRATORY TRACT INFECTION; RHINITIS; SINUSITIS; STEROID THERAPY; VIRUS INFECTION; VOMITING;

ADMINISTRATION, INHALATION; ASTHMA; BRONCHODILATOR AGENTS; BUDESONIDE; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INFANT; MALE; RANDOMIZED CONTROLLED TRIALS; RETROSPECTIVE STUDIES;

EID: 0036266573     PISSN: 02770903     EISSN: None     Source Type: Journal    
DOI: 10.1081/JAS-120002472     Document Type: Article

References (24)

1. Chronic asthma: An update
2. Surveillance for asthma - United States, 1960-1995
3. Changes in asthma prevalence: Two surveys 15 years apart
4. A community-based study of the epidemiology of asthma. Incidence Rates, 1964-1983
5. Current issues for establishing inhaled corticosteroids as the antiinflammatory agents of choice in asthma
6. Management of asthma
7. A multiple-dosing placebo-controlled study of budesonide inhalation suspension given once or twice daily for treatment of persistent asthma in young children and infants
8. Treatment of severe steroid dependent preschool asthma with nebulised budesonide suspension
9. Dose titration of nebulized budesonide in young children
10. Rapid induction of clinical response with a short-term high-dose starting schedule of budesonide nebulizing suspension in young children with recurrent wheezing episodes
11. Nebulized budesonide for the treatment of moderate to severe asthma in infants and toddlers
12. Treating childhood asthma with nebulised steroids
13. Clinical need for a nebulized corticosteroid
14. Once-daily budesonide inhalation suspension in infants and children <4 and ≥4 years of age with persistent asthma
15. Efficacy of nebulized budesonide in treatment of severe infantile asthma: A double-blind study
16. Dose-related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma
17. Epidemiology of respiratory infectious diseases
18. Recurrent respiratory tract infections in paediatric patients
19. Randomised placebo-controlled trial of inhaled sodium cromoglycate in 1-4-year-old children with moderate asthma
20. Comparison of fluticasone propionate and sodium cromoglycate for the treatment of childhood asthma (an open parallel group study)
21. Effects of regular inhalation of beclomethasone dipropionate and sodium cromoglycate on bronchial hyperreactivity in asthmatic children